This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Alembic Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Innovations of Anand Kumar Pandey
Introduction
Anand Kumar Pandey is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work has led to the filing of multiple patents, showcasing his innovative approach to drug formulation.
Latest Patents
Anand Kumar Pandey holds 2 patents. His latest patents include a process for preparing Valsartan. This invention relates to a novel compound of formula (IV), which is an organic acid salt of N-[(2'-cyanobiphenyl-4-yl)methyl]-(L)-valine ester. This compound serves as a useful intermediate for the preparation of Valsartan, chemically known as (S)-N-(1-Carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]amine. The invention also details a process for preparing Valsartan using this novel intermediate.
Career Highlights
Anand Kumar Pandey is currently employed at Alembic Limited, a prominent pharmaceutical company. His role involves research and development, focusing on innovative drug formulations that can improve patient outcomes. His expertise in organic chemistry has been instrumental in advancing the company's product offerings.
Collaborations
Anand has collaborated with several talented individuals in his field, including Rohit Ravikant Soni and Sanjay Lakhabhai Vasoya. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the innovation process.
Conclusion
Anand Kumar Pandey's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight his commitment to innovation. His work continues to pave the way for advancements in drug development, benefiting both the industry and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
